
US biopharma firm Cubist Pharmaceuticals has named Robert Perez as its chief executive and who will begin the role from …
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical

